Entecavir

Janessa Smith, Pharm.D. BCPS, Paul A. Pham, Pharm.D.
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID
Entecavir is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of chronic hepatitis B (HBV) infection in adults and children at least 2 years of age with evidence of active disease (active viral replication, elevated ALT or AST or histologic evidence of active disease).

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Treatment of chronic hepatitis B (HBV) infection in adults and children at least 2 years of age with evidence of active disease (active viral replication, elevated ALT or AST or histologic evidence of active disease).

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 2, 2017